Clinical Trials Overview

We are devoted to discovering and developing medicines that reduce suffering and improve the lives of patients with immune diseases and the most difficult-to-treat cancers. As part of that process, we must conduct clinical trials to establish their efficacy, safety and tolerability to gain approval from regulatory agencies in the United States and around the world.

Patient participation in clinical trials is important. If you are chosen to enroll in one of our trials, you will be participating in important health research and helping to advance the scientific understanding of cancer.

Read more to see where our clinical trial sites are located and the types of diseases for which we are evaluating our investigational medicines.

Find Clinical Trials Near Me

Study Phase	Disease Type(s)	Investigational Medicine	Status
Phase 1	Atopic dermatitis	Soquelitinib	Enrolling	More Info
Phase 1/1b	Multiple solid tumors	CPI-006 CPI-006 + ciforadenant CPI-006 + pembrolizumab CPI-006 + pembrolizumab + ciforadenant	Enrolling*
Phase 3	Peripheral T-Cell Lymphoma	Soquelitinib	Enrolling	More Info
Phase 1/1b	T-Cell Lymphomas	Soquelitinib	Enrollment Complete	More Info
Phase 1b/2	Renal cell carcinoma (RCC)	Ciforadenant + ipilimumab and nivolumab	Enrolling	More Info

*Corvus partner, Angel Pharmaceuticals, is enrolling this clinical trial in China.

Corvus Expanded Access Policy

For more information on our product candidates, please see our Annual Report available in the SEC Filings section of the website.